Podcast

Ultrafiltration in Heart Failure: Truth or Fantasy?

Presented at the 6th Annual Dartmouth Conference on Advances in Heart Failure at the Dartmouth Hitchcock Medical Center, Lebanon, N.H.

Maria Rosa Costanzo, MD, medical director, Midwest Heart Specialists heart failure and pulmonary hypertension programs; Medical Director, Edward Hospital Center for Advanced Heart Failure, Edward Heart Hospital, Naperville, Ill., discusses “Ultrafiltration in Heart Failure: Truth or Fantasy?” Presented at the 6th Annual Dartmouth Conference on Advances in Heart Failure, held Monday, May 24, 2010, at the Dartmouth Hitchcock Medical Center, Lebanon, N.H.

Click here to access this third-party resource.

Related Videos
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
Muthiah Vaduganathan, MD, MPH | Credit: Brigham and Women's Hospital
Viet Le, DMSc, PA-C | Credit: APAC
Marianna Fontana, MD, PhD: Declines in Kidney Function Frequent in ATTR-CM | Image Credit: Radcliffe Cardiology
Related Content
US FDA logo in black over a white background. | Credit: US Food and Drug Administration
November 23rd 2024

FDA Approves Acoramidis (Attruby) for ATTR-CM

Patrick Campbell
Medical Ethics Unpacked: Ethical Considerations for Euthanasia and Medically-Assisted Suicide
November 22nd 2024

Medical Ethics Unpacked: Ethical Considerations for Euthanasia & Medical Assistance in Dying

Steven Levine, MD Dominic Sisti, PhD
Steve Nissen, MD | Credit: Cleveland Clinic
November 18th 2024

Zerlasiran 60-Week Data Reinforce Lp(a) Reductions Observed in ALPACAR-360

Patrick Campbell
Medical Ethics Unpacked:
November 22nd 2024

Medical Ethics Unpacked: Ethical Foundations and Background of Euthanasia & Medically-Assisted Suicide

Steven Levine, MD Dominic Sisti, PhD
Bumetanide Nasal Spray Equivalent to Oral, IV Forms for Heart Failure| Image Credit: American Heart Association
November 18th 2024

Bumetanide Nasal Spray Equivalent to Oral, IV Forms for Heart Failure

Connor Iapoce
Sacubtril/Valsartan Lowers Risk of Cardiotoxicity Linked to Chemotherapy | Image Credit: American Heart Association
November 18th 2024

Sacubtril/Valsartan Lowers Cardiotoxicity Risk Linked to Chemotherapy

Connor Iapoce
© 2024 MJH Life Sciences

All rights reserved.